Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline, the advanced technologies and the committed and highly competent group of individuals that moves the company forward.

These events will be held on Zoom and open to the public, reflecting the company's commitment to transparency and engagement with the community. The first three presentations are scheduled for April 9th, May 8th, and June 12th.

The presentations represent an opportunity for participants to gain insights into our drug development process and engage with the team during the Q&A sessions that will follow each presentation.

These will be open meetings but we would appreciate if you subscribe to our newsletters, so that we can send you information in the future (please register at  https://hamletbiopharma.com/subscribe/).

For more information please contact:

Martin Erixon, CEO, Hamlet BioPharma AB, +46 733 00 43 77

martin.erixon@hamletpharma.com

Catharina Svanborg, Chairman of the board, Hamlet BioPharma AB, +46 709 42 65 49,

catharina.svanborg@hamletpharma.com